Revenue
2024
2025
JUPITER NEUROSCIENCES, INC. (JUNS)
Price—Loading quote
Net income
2023
2024
2025
Free cash flow
No reported data
Total cash / debt
CashTotal debt
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Revenue | $21,796 | $0 | — |
| Gross profit | $17,565 | — | — |
| Research & development | $2.1M | $492,660 | $954,793 |
| Operating expenses | $8.9M | $3.1M | $3.9M |
| Operating income | −$8.9M | −$3.1M | −$3.9M |
| Net income | −$8.6M | −$2.4M | −$4.8M |
| Basic EPSper diluted share | -$0.25 | -$0.08 | -$0.18 |
| Diluted EPSper diluted share | -$0.25 | -$0.08 | -$0.18 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 1, 2025Form 4 | Silva Alison D.Pres + Chief Business Officer | BuyCommon Stock | 250 | $1.03 | $257.50 | 112.8K |
| Jul 1, 2025Form 4 | Silva Alison D.Pres + Chief Business Officer | BuyCommon Stock | 250 | $1.03 | $257.50 | 112.5K |
| Jul 1, 2025Form 4 | Silva Alison D.Pres + Chief Business Officer | BuyCommon Stock | 250 | $1.03 | $257.50 | 112.3K |
| Jul 1, 2025Form 4 | ROSEN CHRISTERCEO and Chairman | BuyCommon Stock | 3.1K | $1.02 | $3.2K | 11.08M |
| Jul 1, 2025Form 4 | ROSEN CHRISTERCEO and Chairman | BuyCommon Stock | 500 | $1.01 | $505.00 | 11.08M |